Research Grade Biosimilar Antibodies

Low endotoxin levels
Hot Target Coverage
Validated binding activity

What are Biosimilar Antibodies?

Biosimilar antibodies are research-grade antibodies that are highly similar in structure, function and sequences to the approved original therapeutic antibodies. They are produced through recombination technology and have the same variable regions from the corresponding therapeutic antibodies, which making them reliable and more cost-effective research tools and alternative reagents in drug development and basic research.

CUSABIO has successfully expressed and validated many research-grade biosimilar antibodies, covering a variety of popular targets. All these research-grade biosimilar antibodies can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.

Why Choose CUSABIO Biosimilar Antibodies?

Identical Variable Region Sequence

Our biosimilar antibodies are recombinantly expressed in mammalian cells with unmodified variable and Fc regions identical to the approved therapeutic antibodies.

Broad Range of Targets

We offer over 200 ready-to-use biosimilar antibodies covering key targets, including immune checkpoints, tumor drivers, and neurological markers.

Validated Binding Activity

Each batch is ELISA-validated for strong target binding and comes with an EC50 value for reliable performance.

Stable Supplies of Various Scale

We offer stable supply of research-grade biosimilar antibodies from ul to g level, proving multiple options to customers.

Common Application Scenarios

icon

Mechanism Research and Functional Validation

Serve as highly similar research tools for in vitro assessment of biological activities such as cytotoxicity and blocking effects of antibody drugs, enabling in-depth investigation into their mechanisms of action.

icon

Drug Development and Quality Control Analysis

Used as critical reference standards or surrogate materials in the development of pharmacokinetic (PK) and immunogenicity (ADA) assays, facilitating method validation and bioequivalence evaluation.

icon

Assay and Diagnostic Development

Function as reliable positive controls in Flow Cytometry, IHC, and other detection platforms, or are utilized in the development of companion diagnostics to ensure assay specificity and accuracy.

icon

Preclinical In Vivo Efficacy Evaluation

With formulations suitable for in vivo administration, they can be directly applied in animal models for efficacy assessment and dose exploration, providing a foundation for preclinical research.

Product Catalog

Don't see your desired biosimilar in the catalog below? We also offer a High-Throughput Recombinant Antibody Production Service to develop custom antibodies for any target – at the same competitive price point. Learn more

Code Product Name
CSB-RA016133MB2HU NTRK1 (BR01T Biosimilar) Recombinant Monoclonal Antibody
CSB-RA017765MB1HU PEAR1 (SV001 Biosimilar) Recombinant Monoclonal Antibody
CSB-RA009939MB1HU GRN (AG-01 Biosimilar) Recombinant Monoclonal Antibody
CSB-RA044639MB1I GD3 ganglioside (Ecromeximab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA320223MB1BQE pagA Antigen (Obiltoxaximab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA336462MB1FKZ spa (Omodenbamab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA853494MB2HU FCRL5 (DFRF4539A (RG-7598) Biosimilar) Recombinant Monoclonal Antibody
CSB-RA011880MB2HU ITGB1 (OS-2966 Biosimilar) Recombinant Monoclonal Antibody
CSB-RA898797MB1HU TAG-72 (Minretumomab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA005983MB2HU CRLF2 (Solrikitug Biosimilar) Recombinant Monoclonal Antibody
CSB-RA621524MB2HU KLRB1 (Rezorstobart Biosimilar) Recombinant Monoclonal Antibody
CSB-RA015950MB2HU NOTCH2 (Tarextumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA006045MB6HU CSF2 (Namilumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA004953MB2HU CD7 (Grisnilimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA801822MB3HU VTCN1 (Puxitatug Biosimilar) Recombinant Monoclonal Antibody
CSB-RA704410MB4HU MUC16 (Sofituzumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA867155MB2HU SLITRK6 (Sirtratumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA154670MB1HU IgE (Talizumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA592139MB1HU OxLDL (Orticumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA012928MB2HU LIF (Falbikitug Biosimilar) Recombinant Monoclonal Antibody
CSB-RA357716MB1FKZ Toxin A (Tosatoxumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA004943MB4HU CD52 (Gatralimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA012871MB2HU LEPR (Mibavademab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA016331MB2HU OLR1 (Golocdacimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA003658MB2HU C2 (Empasiprubart Biosimilar) Recombinant Monoclonal Antibody
CSB-RA011050MB5HU IFNG (Fontolizumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA011864MB2HU ITGA2 (Vatelizumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA004900MB3HU CD22 (Moxetumomab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA007765MB9HU ERBB3 (Duligotuzumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA872537MB3HU IL21 (Avizakimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA023462MB2HU TGM2 (Zampilimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA011661MB13HU IL4R (Manfidokimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA003995MB13HU C5 (Crovalimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA621767MB3HU SELPLG (Neihulizumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA023446MB4HU TGFB1 (Metelimumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA984018MB1DO IL-31 (Lokivetmab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA011087MB14HU IGF1R (Figitumumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA890691MB2HU STEAP1 (Vandortuzumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA16849MB2HU IGHE (Quilizumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA004895MB2HU CD200 (Samalizumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA618886MB3HU LRRC32 (Livmoniplimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA007717MB3HU EPCAM (Tucotuzumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA159341MB20HU EGFR (Tomuzotuximab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA017647MB13HU PCSK9 (Frovocimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA614985MB1HU AMHR2 (Murlentamab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA675446MB18HU TIGIT (Tamgiblimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA012719MB16HU LAG3 (Ieramilimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA619964MB54HU PDCD1 (Acrixolimab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA878862MB3HU DLL4 (Enoticumab Biosimilar) Recombinant Monoclonal Antibody
CSB-RA887154MB1HU RSPO3 (Rosmantuzumab Biosimilar) Recombinant Monoclonal Antibody

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2026 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1